Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN gastrointestinal disorder
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Ekin Pellegrini has lofty goals as president of the Executive DBA Council
Pellegrini’s fascinating life and career path, from Turkey to UMSL with several stops along the way, has prepared her to lead the Executive DBA Council.
MORE IN gastrointestinal disorder
LATEST NEWS
- Ekin Pellegrini has lofty goals as president of the Executive DBA Council
- UMSL receives INSIGHT Into Diversity magazine’s Higher Education Excellence in Diversity Award for the fifth straight year
- Associate Professor Emerita Chikako Usui honored by Japanese government for outstanding contribution to Japan-U.S. relations
- UMSL partnering with World Wide Technology to offer educational opportunities to employees looking to move forward in their careers
- Helena Marvin, Lori Curtis and Daniel Gerth receive UMSL Hero Awards
- Community members gather to celebrate 30 years of Greek Studies at UMSL
- Eye on UMSL: Work in progress
- Provost Steven Berberich announces 17 faculty promotions for the 2024-25 academic year
- UMSL Tritons weekly rewind
- Ken and Nancy Kranzberg receive 2024 E. Desmond and Mary Ann Lee Medal for Philanthropy at Founders Celebration
